Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES) | MicrobiomeTrials← Back to trialsNCT00006150
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 600 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent TuberculosisTuberculosisExtensively Drug-Resistant Tuberculosis
Background:
\- Tuberculosis (TB) is an infectious disease that affects numerous people worldwide. Researchers are inter…
Bethesda, United States
Rifampicin-Resistant Pulmonary TuberculosisMultidrug-Resistant Pulmonary Tuberculosis
This is a Phase 3, randomized, open-label, active-controlled, multicenter trial evaluating the efficacy, safety, and tol…
Beijing, ChinaEst. completion Sep 29, 2028
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaPediatric CancerPediatric ALL, RelapsedPediatric ALLPediatric ALL, B CellAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaPediatric AMLR/R AMLR/R B-cell ALL
The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescen…
Multiple LocationsEst. completion Apr 30, 2030